Rosalia Gonzales, Pfizer
Rosalia Gonzales, Director of Compound Management and Distribution, Worldwide Research and Development, Pfizer Connecticut Laboratories, Medicinal Sciences
Be part of a diverse community of innovators committed to the growth and sustainability our bioscience community.
Your source for today’s talent, job opportunities and career development.
Spend more on science with exclusive, members-only discount programs.
Boost your visibility and show your support for Connecticut’s bioscience community.
Dedicated to the growth of a vibrant bioscience ecosystem, our organization connects companies, institutions, entrepreneurs, investors, government, service providers, and other passionate, dedicated people to improve patients’ lives and public health.
Please Join A Breakfast Roundtable Discussion The Opportunity Zones program, an important new federal incentive to grow businesses through long-term investments in low-income communities, has...
Fabulous food, fun, and friends, followed by amazingly creative entrepreneurs pitching for $10,000 or more in grants – all in one of the state’s most...
Industry, Academic, Government: Collaboration to Prepare Connecticut’s Workforce The event will feature introductions by legislative and academic leaders in Connecticut, talks by pioneers in the...
The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and...
Innovation Commons offers commercial-grade labs, offices, co-working and special event spaces at cost-effective prices and flexible lease terms. Located halfway between Boston and New York City, in southeast coastal CT, Innovation Commons is led by a team of experienced entrepreneurs and scientists. Come experience a hassle-free, full-service professional space combined with a supportive community whose mission is to help you succeed.
BioCT keeps policy makers abreast of the latest developments and changing needs of the bioscience community, ensuring policy alignment at the state and federal level.
Achillion reports that it achieved threshold enrollment in the Phase 2 trials of ACH-4471 for patients with C3 glomerulopathy (C3G), a devastating disease affecting the...
GSK’s ViiV secured FDA approval for Dovato after submitting a marketing application with a priority review voucher (PRV) last October. The drug is used to treat...
A new collaboration between UConn Health and the Foundation for Prader-Willi Research will create a centralized, high quality biobank of stem cells to help researchers...